Literature DB >> 18707892

Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring.

Kiminori Ohta1, Tokuhito Goto, Shinya Fijii, Tomoharu Suzuki, Shigeru Ohta, Yasuyuki Endo.   

Abstract

We previously developed carborane-containing potent AR antagonists, BA321 and BA341, on the basis of our hypothesis that the carborane cage would be an excellent hydrophobic pharmacophore in place of steroidal C and D rings. As an extension of that work, we designed and synthesized carborane-containing AR antagonist candidates with a pyridine ring. Compound 6b, which has a pyridine ring directly bound to the p-carborane cage at the 3-position, exhibited potent AR-antagonistic activity in transcriptional activation assay using NIH3T3 cells transfected with a hAR-expression plasmid. In addition, it showed more potent antiandrogenic activity than that of the well-known antiandrogen flutamide and comparable activity to that of (R)-bicalutamide in SC-3 cell proliferation assay.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18707892     DOI: 10.1016/j.bmc.2008.07.055

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

Review 1.  Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance.

Authors:  Xiaohong Tian; Yang He; Jinming Zhou
Journal:  Front Pharmacol       Date:  2015-03-24       Impact factor: 5.810

2.  Transition metal-free oxidative and deoxygenative C-H/C-Li cross-couplings of 2H-imidazole 1-oxides with carboranyl lithium as an efficient synthetic approach to azaheterocyclic carboranes.

Authors:  Lidia A Smyshliaeva; Mikhail V Varaksin; Pavel A Slepukhin; Oleg N Chupakhin; Valery N Charushin
Journal:  Beilstein J Org Chem       Date:  2018-10-12       Impact factor: 2.883

Review 3.  Carboranes as unique pharmacophores in antitumor medicinal chemistry.

Authors:  Yu Chen; Fukuan Du; Liyao Tang; Jinrun Xu; Yueshui Zhao; Xu Wu; Mingxing Li; Jing Shen; Qinglian Wen; Chi Hin Cho; Zhangang Xiao
Journal:  Mol Ther Oncolytics       Date:  2022-01-10       Impact factor: 7.200

4.  Development of Androgen-Antagonistic Coumarinamides with a Unique Aromatic Folded Pharmacophore.

Authors:  Hitomi Koga; Mai Negishi; Marie Kinoshita; Shinya Fujii; Shuichi Mori; Mari Ishigami-Yuasa; Emiko Kawachi; Hiroyuki Kagechika; Aya Tanatani
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923

Review 5.  The Boron Advantage: The Evolution and Diversification of Boron's Applications in Medicinal Chemistry.

Authors:  Katia Messner; Billy Vuong; Geoffrey K Tranmer
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.